Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(5)
•••
Comment by ronzon Mar 02, 2015 1:46pm
111 Views
Post# 23480705

RE:RE:RE:RE:Did Nuvo attend this expert confetence?

RE:RE:RE:RE:Did Nuvo attend this expert confetence?
Well put geos571, there is a huge lesson from "Not" being the first to market a product, as is referenced from the Pennsaid vs Voltaren sales.
We were well ahead of Voltaren and should have been to market much sooner, However, this same management team fumbled the ball so many times that we were beat cleanly to be the first to market and it cost us unknown millions in lost revenue! Something that were "still" trying to get a more suitable percentage of the Arthritis pain market, but this is what we get with the current management. Private enterprise would have fired the whole lot of them long ago!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities